Completed PHASE1 INTERVENTIONAL 1-arm NCT02250430

A Phase 1 Study Assessing Local Cutaneous Effects of SB204

A Phase 1, Single-Center, Split-Face Study Assessing Local Cutaneous Effects After Application of SB204 2% and SB204 4% in Healthy Volunteers

Sponsor: Novan, Inc.

Conditions Acne Vulgaris

Interventions SB204

Updated 8 times since 2017 Last updated: Nov 15, 2018 Started: Sep 30, 2014 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Acne Vulgaris, this trial is completed. The trial is conducted by Novan, Inc. and has accumulated 8 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Dec 2018 — Jan 2021 [monthly]

Completed PHASE1
Nov 2018 — Dec 2018 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

Jun 2018 — Nov 2018 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novan, Inc.

Data source: Novan, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Broomall, United States